208 related articles for article (PubMed ID: 24900981)
1. Correlation of altered expression of the autophagy marker LC3B with poor prognosis in astrocytoma.
Winardi D; Tsai HP; Chai CY; Chung CL; Loh JK; Chen YH; Hsieh CL
Biomed Res Int; 2014; 2014():723176. PubMed ID: 24900981
[TBL] [Abstract][Full Text] [Related]
2. Reduced expression of LC3B-II and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumors.
Huang X; Bai HM; Chen L; Li B; Lu YC
J Clin Neurosci; 2010 Dec; 17(12):1515-9. PubMed ID: 20863706
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma stem cells resistant to temozolomide-induced autophagy.
Fu J; Liu ZG; Liu XM; Chen FR; Shi HL; Pangjesse CS; Ng HK; Chen ZP
Chin Med J (Engl); 2009 Jun; 122(11):1255-9. PubMed ID: 19567133
[TBL] [Abstract][Full Text] [Related]
4. CD90 is identified as a candidate marker for cancer stem cells in primary high-grade gliomas using tissue microarrays.
He J; Liu Y; Zhu T; Zhu J; Dimeco F; Vescovi AL; Heth JA; Muraszko KM; Fan X; Lubman DM
Mol Cell Proteomics; 2012 Jun; 11(6):M111.010744. PubMed ID: 22203689
[TBL] [Abstract][Full Text] [Related]
5. Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance-associated protein genes.
Jin F; Zhao L; Zhao HY; Guo SG; Feng J; Jiang XB; Zhang SL; Wei YJ; Fu R; Zhao JS
Neuroscience; 2008 Jun; 154(2):541-50. PubMed ID: 18462887
[TBL] [Abstract][Full Text] [Related]
6. B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells.
Yao Y; Tao R; Wang X; Wang Y; Mao Y; Zhou LF
Neuro Oncol; 2009 Dec; 11(6):757-66. PubMed ID: 19264916
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas.
Shin JH; Lee YS; Hong YK; Kang CS
J Neurooncol; 2013 Dec; 115(3):333-41. PubMed ID: 24129546
[TBL] [Abstract][Full Text] [Related]
8. The relationship among integrin alpha 7, CD133 and Nestin as well as their correlation with clinicopathological features and prognosis in astrocytoma patients.
Li C; Liu J; Yang W; Chen C; Wu B
Clin Neurol Neurosurg; 2022 Jun; 217():107198. PubMed ID: 35430343
[TBL] [Abstract][Full Text] [Related]
9. Autophagy and lysosomal related protein expression patterns in human glioblastoma.
Giatromanolaki A; Sivridis E; Mitrakas A; Kalamida D; Zois CE; Haider S; Piperidou C; Pappa A; Gatter KC; Harris AL; Koukourakis MI
Cancer Biol Ther; 2014; 15(11):1468-78. PubMed ID: 25482944
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
11. How powerful is CD133 as a cancer stem cell marker in brain tumors?
Cheng JX; Liu BL; Zhang X
Cancer Treat Rev; 2009 Aug; 35(5):403-8. PubMed ID: 19369008
[TBL] [Abstract][Full Text] [Related]
12. The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells.
Lomonaco SL; Finniss S; Xiang C; Decarvalho A; Umansky F; Kalkanis SN; Mikkelsen T; Brodie C
Int J Cancer; 2009 Aug; 125(3):717-22. PubMed ID: 19431142
[TBL] [Abstract][Full Text] [Related]
13. Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis.
Pallini R; Ricci-Vitiani L; Montano N; Mollinari C; Biffoni M; Cenci T; Pierconti F; Martini M; De Maria R; Larocca LM
Cancer; 2011 Jan; 117(1):162-74. PubMed ID: 20806346
[TBL] [Abstract][Full Text] [Related]
14. Autophagy and Apoptosis Play Opposing Roles in Overall Survival of Esophageal Squamous Cell Carcinoma.
Chen HI; Tsai HP; Chen YT; Tsao SC; Chai CY
Pathol Oncol Res; 2016 Oct; 22(4):699-705. PubMed ID: 26980476
[TBL] [Abstract][Full Text] [Related]
15. The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.
Chen S; Jiang YZ; Huang L; Zhou RJ; Yu KD; Liu Y; Shao ZM
Clin Cancer Res; 2013 Dec; 19(24):6853-62. PubMed ID: 24141623
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD133 as a Putative Prognostic Biomarker to Predict Intracranial Dissemination of Primary Spinal Cord Astrocytoma.
Inoue T; Endo T; Nakamura T; Shibahara I; Endo H; Tominaga T
World Neurosurg; 2018 Feb; 110():e715-e726. PubMed ID: 29180077
[TBL] [Abstract][Full Text] [Related]
17. CD133 as a marker for regulation and potential for targeted therapies in glioblastoma multiforme.
Choy W; Nagasawa DT; Trang A; Thill K; Spasic M; Yang I
Neurosurg Clin N Am; 2012 Jul; 23(3):391-405. PubMed ID: 22748652
[TBL] [Abstract][Full Text] [Related]
18. Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy.
Wu A; Wiesner S; Xiao J; Ericson K; Chen W; Hall WA; Low WC; Ohlfest JR
J Neurooncol; 2007 Jun; 83(2):121-31. PubMed ID: 17077937
[TBL] [Abstract][Full Text] [Related]
19. Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer.
Choi J; Jung W; Koo JS
Histopathology; 2013 Jan; 62(2):275-86. PubMed ID: 23134379
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and clinical relevance of the autophago-lysosomal network in human gliomas.
Jennewein L; Ronellenfitsch MW; Antonietti P; Ilina EI; Jung J; Stadel D; Flohr LM; Zinke J; von Renesse J; Drott U; Baumgarten P; Braczynski AK; Penski C; Burger MC; Theurillat JP; Steinbach JP; Plate KH; Dikic I; Fulda S; Brandts C; Kögel D; Behrends C; Harter PN; Mittelbronn M
Oncotarget; 2016 Apr; 7(15):20016-32. PubMed ID: 26956048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
